Annual CFF
$1.19B$1.10B+1,170.30%
Summary
- Current Value
- As of today, RNA annual cash from financing is $1.19B, up +1170.30% on
- Historical Performance
- RNA annual cash from financing is up +576.26% over the past 3 years, and up +1236.23% over the past 5 years
- All-Time High Comparison
- RNA annual cash from financing is currently at its all-time high
- 3-Year Low Comparison
- RNA annual cash from financing is +1170.30% above its 3-year low of $93.86M reached on
- Sector Comparison
- RNA annual cash from financing is higher than 99.07% of companies in Healthcare sector
Cash From Financing Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Financing | $1.19B | +1170.3% | +576.3% | +1236.2% | +10000.0% | |
| Quarterly Cash From Financing | $850.37M | +148.3% | +2046.3% | +10000.0% | +10000.0% | |
| TTM Cash From Financing | $869.80M | -28.1% | +606.3% | +153.3% | +10000.0% | |
| Price | $72.37 | +135.0% | +264.9% | +185.8% | – | |
| Annual Cash From Operations | -$300.87M | -152.7% | -217.3% | -10000.0% | -3016.2% | |
| Annual Cash From Investing | -$854.20M | -556.7% | -935.2% | -10000.0% | -10000.0% | |
| Annual Dividends Paid | $0.00 | 0.0% | 0.0% | -100.0% | 0.0% | |
| Annual Total Debt | $6.80M | -31.0% | -42.0% | -95.1% | -84.2% | |
| Shares Outstanding | 150.68M | +25.7% | +116.0% | +301.1% | – |
Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.19B | at high | |
| 5Y | $1.19B | at high | |
| All | $1.19B | at high |
Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $93.86M | +1170.3% | |
| 5Y | $93.86M | +1170.3% | |
| All | $5.14M | >+9999.0% |
Cash From Financing History
| Year | Value | Change |
|---|---|---|
| $1.19B | +1,170.3% | |
| $93.86M | -72.9% | |
| $346.17M | +96.3% | |
| $176.32M | -35.2% |
| Year | Value | Change |
|---|---|---|
| $272.04M | +204.9% | |
| $89.23M | +1,634.7% | |
| $5.14M | - |
FAQ
What is the current annual cash from financing of RNA?
As of today, RNA annual cash from financing is $1.19B
What is 1-year change in RNA annual cash from financing?
RNA annual cash from financing is up +1170.30% year-over-year
What is 3-year change in RNA annual cash from financing?
RNA annual cash from financing is up +576.26% over the past 3 years
How far is RNA annual cash from financing from its all-time high?
RNA annual cash from financing is currently at its all-time high
How does RNA annual cash from financing rank versus sector peers?
RNA annual cash from financing is higher than 99.07% of companies in Healthcare sector
When is RNA next annual earnings release?
The next annual earnings release for RNA is on
Quarterly CFF
$850.37M$846.59M+22,438.19%
Summary
- Current Value
- As of today, RNA quarterly cash from financing is $850.37M, up +22438.19% on
- Historical Performance
- RNA quarterly cash from financing is up +148.31% year-over-year, and up +2046.30% over the past 3 years
- All-Time High Comparison
- RNA quarterly cash from financing is currently at its all-time high
- 3-Year Low Comparison
- RNA quarterly cash from financing is +2125815.00% above its 3-year low of $40.00K reached on
- Sector Comparison
- RNA quarterly cash from financing is higher than 99.73% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Financing | $850.37M | +10000.0% | +148.3% | +2046.3% | +10000.0% | |
| Annual Cash From Financing | $1.19B | – | +1170.3% | +576.3% | +1236.2% | |
| TTM Cash From Financing | $869.80M | +140.3% | -28.1% | +606.3% | +153.3% | |
| Price | $72.37 | +54.1% | +135.0% | +264.9% | +185.8% | |
| Quarterly Cash From Operations | -$156.17M | +21.8% | -138.0% | -388.7% | -1613.7% | |
| Quarterly Cash From Investing | -$587.93M | -417.0% | -21.9% | -5478.0% | -10000.0% | |
| Quarterly Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $49.97M | +873.0% | +557.4% | +343.2% | +7152.0% | |
| Shares Outstanding | 150.68M | – | +25.7% | +116.0% | +301.1% |
Quarterly Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $850.37M | at high | |
| 3Y | $850.37M | at high | |
| 5Y | $850.37M | at high | |
| All | $850.37M | at high |
Quarterly Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.94M | >+9999.0% | |
| 3Y | $40.00K | >+9999.0% | |
| 5Y | $17.00K | >+9999.0% | |
| All | -$1.35M | >+9999.0% |
Quarterly Cash From Financing History
FAQ
What is the current quarterly cash from financing of RNA?
As of today, RNA quarterly cash from financing is $850.37M
What is RNA quarterly cash from financing most recent change?
RNA quarterly cash from financing was up +22438.19% on September 30, 2025
What is 1-year change in RNA quarterly cash from financing?
RNA quarterly cash from financing is up +148.31% year-over-year
How far is RNA quarterly cash from financing from its all-time high?
RNA quarterly cash from financing is currently at its all-time high
How does RNA quarterly cash from financing rank versus sector peers?
RNA quarterly cash from financing is higher than 99.73% of companies in Healthcare sector
When is RNA next earnings release?
The next earnings release for RNA is on
TTM CFF
$869.80M$507.90M+140.34%
Summary
- Current Value
- As of today, RNA TTM cash from financing is $869.80M, up +140.34% on
- Historical Performance
- RNA TTM cash from financing is down -28.15% year-over-year, and up +606.25% over the past 3 years
- All-Time High Comparison
- RNA TTM cash from financing is currently -28.15% below its historical high of $1.21B set on
- 3-Year Low Comparison
- RNA TTM cash from financing is +826.66% above its 3-year low of $93.86M reached on
- Sector Comparison
- RNA TTM cash from financing is higher than 99.28% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Financing | $869.80M | +140.3% | -28.1% | +606.3% | +153.3% | |
| Annual Cash From Financing | $1.19B | – | +1170.3% | +576.3% | +1236.2% | |
| Quarterly Cash From Financing | $850.37M | +10000.0% | +148.3% | +2046.3% | +10000.0% | |
| Price | $72.37 | +54.1% | +135.0% | +264.9% | +185.8% | |
| TTM Cash From Operations | -$580.54M | -18.5% | -214.7% | -371.1% | -1897.5% | |
| TTM Cash From Investing | -$309.43M | -51.7% | +58.1% | -16.2% | -10000.0% | |
| TTM Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | -100.0% | |
| Quarterly Total Debt | $49.97M | +873.0% | +557.4% | +343.2% | +7152.0% | |
| Shares Outstanding | 150.68M | – | +25.7% | +116.0% | +301.1% |
TTM Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.19B | N/A | -27.1% |
| 3Y | $1.21B | -28.1% | |
| 5Y | $1.21B | -28.1% | |
| All | $1.21B | -28.1% |
TTM Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $361.90M | +140.3% | |
| 3Y | $93.86M | +826.7% | |
| 5Y | -$456.00K | >+9999.0% | |
| All | -$456.00K | >+9999.0% |
TTM Cash From Financing History
FAQ
What is the current TTM cash from financing of RNA?
As of today, RNA TTM cash from financing is $869.80M
What is RNA TTM cash from financing most recent change?
RNA TTM cash from financing was up +140.34% on September 30, 2025
What is 1-year change in RNA TTM cash from financing?
RNA TTM cash from financing is down -28.15% year-over-year
How far is RNA TTM cash from financing from its all-time high?
RNA TTM cash from financing is currently -28.15% below its historical high of $1.21B set on September 30, 2024
How does RNA TTM cash from financing rank versus sector peers?
RNA TTM cash from financing is higher than 99.28% of companies in Healthcare sector
When is RNA next earnings release?
The next earnings release for RNA is on
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
Data Sources & References
- RNA Official Website www.aviditybiosciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1599901/000159990125000210/0001599901-25-000210-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1599901/000159990125000059/0001599901-25-000059-index.htm
- RNA Profile on Yahoo Finance finance.yahoo.com/quote/RNA
- RNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rna